Search Blog
Categories
October 2013
M T W T F S S
« Sep   Nov »
 123456
78910111213
14151617181920
21222324252627
28293031  

Tags

SIRI, ZIOP, PRKR and CLSN added to NASDAQ Active Stock Watch List at EPR

admin

By Equity Profile Report

New York, NY – (ACCESSWIRE) – 10/24/2013 – Equity Profile Report initiates its NASDAQ Active Stock Watch List adding SIRIUS XM Radio Inc. (NASDAQ:SIRI), ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Parkervision Inc. (NASDAQ:PRKR), and Celsion Corp. (NASDAQ:CLSN) 

SIRIUS XM Radio Inc. (NASDAQ:SIRI) a company that provides satellite radio services in the United States and Canada is currently down (-2.34%) on 43,160,459 shares traded after SiriusXM reported its Third Quarter 2013 Results. SIRIUS XM Radio Inc. (NASDAQ:SIRI) is currently down (-7.42%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about SIRIUS XM Radio Inc. (NASDAQ:SIRI) 

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=SIRI&SubId=AW 

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) a biopharmaceutical company that focuses on the discovery and development of new cancer therapies is currently down (-5.71%) on 5,178,375 shares traded after ZIOPHARM priced public offering of 14.3 million shares of its common stock at $3.50 per share. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) is currently down (-39.33%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) 

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=ZIOP&SubId=AW 

Parkervision Inc. (NASDAQ:PRKR) a company that designs, develops, and markets proprietary radio frequency technologies and products for use in semiconductor circuits for wireless communication products in the United States is currently up (+0.99%) on 1,349,925 shares traded after ParkerVision announced that its Common Stock will Resume Trading on Thursday Morning. Parkervision Inc. (NASDAQ:PRKR) is currently up (+385.53%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Parkervision Inc. (NASDAQ:PRKR) 

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=PRKR&SubId=AW 

Celsion Corp. (NASDAQ:CLSN) an oncology drug development company that focuses on the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology is currently up (+7.68%) on 2,655,850 shares traded after Celsion Corporation Provided Clinical Update on ThermoDox HEAT Study Findings. Celsion Corp. (NASDAQ:CLSN) is currently up (+74.67%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Celsion Corp. (NASDAQ:CLSN) 

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=CLSN&SubId=AW 

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.equityprofilereport.com/

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures. 

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com